药食同源起源与展望

药食同源物质在我国的发展历史悠久。其理论最早出现在《黄帝内经》，《神农本草经》《千金方》进行了不同程度的完善。我国对药食同源物质的管理制度从20世纪80年代开始逐步建立，到2021年11月，我国药食同源物质正式进入依法管理阶段，同时也标志着我国药食同源物质相关产业正式成为中医药行业不可或缺的组成部分。药食同源物质可作为药粥、药酒、药茶、煲汤料、刺身等多种形式使用，预包装食品也将是今后药食同源物质研究和发展的方向。发展药食同源物质，不仅是弘扬中医药文化的发展需要，也契合健康中国的发展理念，顺应社会老龄化的发展趋势，并能够促进中药产业多元化。药食同源物质的发展应注重安全性、可控性，需要建立可追溯的质量体系、药食同源物质的评价和标准，推动药食同源文化传播，扩大国际影响力。

Origin and Prospect of Homology Medicine and Food

Medicine and food homology has a long history in China. It was first recorded in Huangdi''s Internal Classic and then upgraded in Shennong''s Classic of Materia Medica and Important Formulas Worth a Thousand Gold Pieces. The management of substances consumed as both medicine and food started in the 1980s in China, and the legal management began on November 2021, making an indispensible role of them in the traditional Chinese medicine (TCM) industry. These substances can be used as raw materials for medicinal porridge, medicinal wine, medicinal tea, soup, sashimi, etc. Pre-packaged food will also be the goal of future research and development of such substances. The development of them plays an important role in promoting TCM culture, accords with the initiative of Healthy China, meets the needs of the greying society, and diversifies the TCM industry. The development of medicine and food from the same source should highlight the safety and controllability. Moreover, efforts should be made to establish traceable quality system, evaluation system, and evaluation standard for such substances. In addition, we should promote the spread of such culture and enhance international influence.